Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 1/20 | 0.36 |
| ▸ | CDC25A | P30304 | 3/20 | 0.33 |
| ▸ | CDC25B | P30305 | 2/20 | 0.33 |
| ▸ | AKT1 | P31749 | 10/20 | 0.32 |
| ▸ | FNTA | P49354 | 1/20 | 0.31 |
| ▸ | FNTB | P49356 | 1/20 | 0.31 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.31 |
| ▸ | KDM4A | O75164 | 1/20 | 0.31 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.31 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6060493 | 1.00 | HSD11B1 (0.36) | HSD11B1CDC25ACDC25BAKT1FNTA | |
| SCHEMBL6060991 | 0.95 | HSD11B1 (0.37) | HSD11B1CDC25ACDC25BFNTAFNTB | |
| SCHEMBL6061003 | 0.85 | AKT1 (0.42) | AKT1 | |
| SCHEMBL6060420 | 0.85 | AKT1 (0.42) | AKT1 | |
| SCHEMBL6060516 | 0.84 | AKT1 (0.40) | AKT1 | |
| SCHEMBL6059939 | 0.83 | CHRNA7 (0.37) | — | |
| SCHEMBL6060312 | 0.83 | CHRNA7 (0.37) | — | |
| SCHEMBL5072440 | 0.82 | AKT1 (0.36) | AKT1 | |
| SCHEMBL6060683 | 0.81 | CHRNA7 (0.38) | — | |
| SCHEMBL6060486 | 0.79 | EP300 (0.33) | HSD11B1AKT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2006045246-A1 | CYCLOPENTANE CARBOXYLATE COMPOUNDS, PROCESS AND INTERMEDIATES FOR PREPARING THE SAME AND USE THEREOF | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2006-05-04 | — | — | WO | disclosed |